New rules: FDA revises regulations to focus on health

Article

Washington, DC-The FDA is revising its rules for safe drug manufacturing to direct more attention and resources to the aspects of manufacturing that pose the greatest risk to public health. It is the first time in 25 years the FDA is amending its rules.

Related Videos
This series features 1 KOL.
This series features 1 KOL.
This series features 1 KOL.
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
© 2024 MJH Life Sciences

All rights reserved.